Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Accenture
Dow
Healthtrust
Moodys
McKinsey
Daiichi Sankyo
Julphar
US Army
Federal Trade Commission

Generated: February 21, 2018

DrugPatentWatch Database Preview

Gemfibrozil - Generic Drug Details

« Back to Dashboard

What are the generic sources for gemfibrozil and what is the scope of gemfibrozil freedom to operate?

Gemfibrozil
is the generic ingredient in two branded drugs marketed by Mylan, Purepac Pharm, Pfizer Pharms, Apotex, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Caribe Holdings, Chartwell Molecules, Hikma Pharms, Impax Pharms, Invagen Pharms, Northstar Hlthcare, Sun Pharm Inds Inc, Teva, Watson Labs, and Yaopharma Co Ltd, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for gemfibrozil. Fifty-three suppliers are listed for this compound. There is one tentative approval for this compound.
Medical Subject Heading (MeSH) Categories for gemfibrozil
Tentative approvals for GEMFIBROZIL
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up300MGCAPSULE;ORAL

US Patents and Regulatory Information for gemfibrozil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs GEMFIBROZIL gemfibrozil TABLET;ORAL 074156-001 Oct 24, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer Pharms LOPID gemfibrozil CAPSULE;ORAL 018422-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Inc GEMFIBROZIL gemfibrozil TABLET;ORAL 079239-001 Dec 29, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer Pharms LOPID gemfibrozil CAPSULE;ORAL 018422-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd GEMFIBROZIL gemfibrozil TABLET;ORAL 202726-001 Sep 16, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cadila Pharms Ltd GEMFIBROZIL gemfibrozil TABLET;ORAL 203266-001 Jun 17, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Purepac Pharm GEMFIBROZIL gemfibrozil CAPSULE;ORAL 072929-001 Jan 29, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex GEMFIBROZIL gemfibrozil TABLET;ORAL 075034-001 Jul 20, 1998 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Pharms GEMFIBROZIL gemfibrozil TABLET;ORAL 078599-001 Aug 16, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Chartwell Molecules GEMFIBROZIL gemfibrozil TABLET;ORAL 074270-001 Sep 27, 1993 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for gemfibrozil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms LOPID gemfibrozil CAPSULE;ORAL 018422-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pfizer Pharms LOPID gemfibrozil CAPSULE;ORAL 018422-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Healthtrust
QuintilesIMS
Queensland Health
Mallinckrodt
Fish and Richardson
UBS
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot